pediatric adhd treatment for children maryland

Monarch eTNS for Pediatric ADHD Treatment

The Monarch eTNS (external Trigeminal Nerve Stimulation) device is indicated as a standalone therapy (monotherapy) for the treatment of pediatric ADHD's unwanted symptoms. It is approved for patients ages 7 through 12 years old. The device is used at home under the supervision of a caregiver during periods of sleep.

Ideal patients for this treatment are children who:

  • Cannot tolerate/use stimulants due to side effects or medical contraindications

  • Parents/caregivers who do not want to use medication

  • Patients who, despite being on stimulants, have only a partial response or side effects that prevent dose increases

Additional indications and age groups are being studied, including teens and adults with ADHD. Preliminary data suggests eTNS may be helpful for Autistic children who experience unwanted attention and anxiety symptoms.


The device is FDA approved so it should be covered at least partially by insurance (we will help with this).


The most common side effects observed with eTNS use are: drowsiness, an increase in appetite, trouble sleeping, teeth clenching, headache and fatigue. No serious adverse events have been associated with use of the device.

Holding Hands

5480 Wisconsin Ave,

Suite 223

Chevy Chase, MD 20815

Tel:  301.576.6044

Fax: 301.576.1645

Send e-mail >>


  • Washington Behavioral Medicine Associates LinkedIn
  • Washington Behavioral Medicine Associates Facebook
  • Washington Behavioral Medicine Associates Twitter
  • Washington Behavioral Medicine Associates Instagram




8:30am to 5:30pm*



Admin Office Closed

*Clinicians may be available to schedule appointments outside these hours


Scan this QR code with your smartphone to enter WBMA's contact information.

© 2021 by Washington Behavioral Medicine Associates, LLC